Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB-RWLC vs CEPHALEXIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEMIPLIMAB-RWLC vs CEPHALEXIN: Safety Overview

Metric CEMIPLIMAB-RWLC CEPHALEXIN
Total FAERS Reports 1,554 7,901
Deaths Reported 323 295
Death Rate 20.8% 3.7%
Hospitalizations 441 1,832
Average Patient Age 70.2 yrs 54.7 yrs
% Female Patients 40.6% 73.4%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A AMELLA PHARMA, LLC
Route N/A ORAL
Marketing Status Prescription Discontinued